Topic: Diabetes

Scientists at Klick Applied Sciences say they discovered a way to use a continuous glucose […]

Ypsomed announced that its mylife Loop now has authorization to work with the Abbott FreeStyle […]

Israeli startup AEYE Health announced last week it had received FDA 510(k) clearance for its […]

Deloitte today released its “North America Technology Fast 500” list of growing companies, including a […]

A Stanford Medicine study observed the apparent curing of diabetes in mice following transplantation of […]

Tandem Diabetes Care (Nasdaq:TNDM) announced that a study of adults with type 2 diabetes supported […]

The Industrial Technology Research Institute, a non-profit R&D organization in Taiwan, has unveiled its AI-assisted […]

Ascensia Diabetes Care announced today that it has updated its Eversense Continuous Glucose Monitoring system app […]

These days, employer-sponsored wellness programs are a dime a dozen—but Verily may have hit the […]

Sernova announced today that it received approval for a protocol amendment in the trial of its […]

Medtronic (NYSE:MDT) Canada announced today that Health Canada granted a license to its MiniMed 780G […]

Dexcom (Nasdaq:DXCM) shares ticked up after hours today on third-quarter results that came in ahead […]

Kennesaw State University researchers developed a way to improve the glucose monitoring process for those […]

Dexcom (Nasdaq:DXCM) announced today that it launched Dexcom U, an NIL (name, image, likeness) program […]

Ochsner Health, a 47-hospital health system based in Louisiana, recently released the results of its digital health […]

Eyenuk, a Los Angeles company that makes technology for eye screenings, raised $26 million on Monday […]

Dive Brief: The ability to customize open-source, “do-it-yourself” automated insulin delivery (AID) systems may make them […]

Dive Brief: A randomized controlled trial has linked Abbott’s FreeStyle Libre 2 continuous glucose monitor (CGM) to […]

Researchers from the Indian Institute of Science’s Robert Bosch Centre for Cyber-Physical Systems have teamed […]

Analysts see a new proposed local coverage determination (LCD) from CMS as a potential boost […]

Engineers at MIT have collaborated to develop a robotic drug delivery capsule that is specially […]

Dexcom (Nasdaq:DXCM) announced today that it made the next-generation Dexcom G7 available in a number […]

Sensoria Health and Defender announced today that they launched the Foot Defender powered by Sensoria […]

Dive Brief: A “bionic pancreas” developed by Beta Bionics performed better than the standard of […]

Better Therapeutics (Nasdaq:BTTX) announced today that it submitted a de novo classification request to the […]

On the heels of launching Omnipod 5 in the United States, Insulet has received CE marking […]

Diabeloop today announced 12-month data supporting its hybrid closed-loop DBLG1 automated insulin delivery system. Paris-based […]

Virta Health announced today that a partnership with U-Haul demonstrated positive outcomes from its type […]

There’s a saying that the second time’s the charm. That certainly is the case for […]

Insulet’s Omnipod 5 with the Dexcom G6 CGM. [Image from Insulet] Insulet (Nasdaq:PODD) announced today […]

New Zealand’s Ministry of Business, Innovation & Employment is backing three local research projects that […]

Abbott (NYSE:ABT) will spend €440 million ($450 million) to expand its operations in Ireland, the […]

Senseonics (NYSE:SENS) shares were up after hours today on second-quarter results that came up shy of […]

Jewelry of the future may be used not only as a fashion accessory but also […]

Senseonics (NYSE:SENS) announced today that Anthem is providing coverage for implantable continuous glucose monitoring (CGM). […]

Dexcom (Nasdaq:DXCM) announced that it made the Dexcom One real-time CGM (rt-CGM) available on prescription […]

Insulet began full market release of its Omnipod 5 insulin pump, the company announced on Monday. The […]

One of medtech’s most anticipated devices is facing yet another delay in obtaining FDA clearance. […]

Tandem Diabetes Care (Nasdaq:TNDM) announced that it acquired infusion set developer Capillary Biomedical. San Diego-based […]